CYC cyclopharm limited

News: CYC Cyclopharm Ltd receives special protocol assessment agreement1 from FDA

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Nov 23 (Reuters) - Cyclopharm Ltd (CYC)

    • Received special protocol assessment (spa ) agreement1 from United States Food And Drug Administration
    • Received special protocol assessment agreement1 for patient trials of its technegas product, to be known as cyc009
    • Approval process remains on track for completion by mid2018 at a cost of less than $7 million usd
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
99.0¢
Change
0.005(0.51%)
Mkt cap ! $110.0M
Open High Low Value Volume
$1.00 $1.00 98.5¢ $6.729K 6.78K

Buyers (Bids)

No. Vol. Price($)
4 558 98.5¢
 

Sellers (Offers)

Price($) Vol. No.
99.0¢ 5540 4
View Market Depth
Last trade - 15.34pm 07/08/2025 (20 minute delay) ?
CYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.